---
figid: PMC5545931__nihms885411f6
figlink: /pmc/articles/PMC5545931/figure/F6/
number: F6
caption: (A) In the canonical pathway, a stable scaffolding complex containing β1
  integrin, RACK1, and IGF-1R activates the FAK-Tyr925/GRB2/ERK pathway, leading to
  tumor cell proliferation, growth, and migration. (B) In WT cells, PSMA expression
  disrupts two pathways, both of which contribute to activation of the more aggressive,
  protumor PI3K-AKT pathway. PSMA physically associates with IGF-1R and RACK1, consistent
  with PSMA disrupting the scaffolding complex, which leads to FAK-Tyr397 hyperphosphorylation
  (“a”), and PSMA expression reverses the phosphorylation of FAK-Tyr925, which is
  required for FAK/GRB2 interactions, thus inactivating ERK signal transduction (“b”).
  (C) Bypassing PSMA interference by directly activating FAK-Tyr925 with extracellular
  matrix (ECM) rescues activation of FAK-Tyr925 and the GRB2/ERK signaling pathway.
  (D) The absence of PSMA allows stable IGF-1R/RACK1/β1 integrin complex formation
  and activation of the FAK-GRB2-ERK canonical pathway, producing less aggressive
  tumors.
pmcid: PMC5545931
papertitle: PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways
  to promote the progression of prostate cancer.
reftext: Leslie Ann Caromile, et al. Sci Signal. ;10(470):eaag3326.
pmc_ranked_result_index: '8346'
pathway_score: 0.874767
filename: nihms885411f6.jpg
figtitle: PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways
  to promote the progression of prostate cancer
year: ''
organisms: Homo sapiens
ndex: 039a8e3a-df11-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5545931__nihms885411f6.html
  '@type': Dataset
  description: (A) In the canonical pathway, a stable scaffolding complex containing
    β1 integrin, RACK1, and IGF-1R activates the FAK-Tyr925/GRB2/ERK pathway, leading
    to tumor cell proliferation, growth, and migration. (B) In WT cells, PSMA expression
    disrupts two pathways, both of which contribute to activation of the more aggressive,
    protumor PI3K-AKT pathway. PSMA physically associates with IGF-1R and RACK1, consistent
    with PSMA disrupting the scaffolding complex, which leads to FAK-Tyr397 hyperphosphorylation
    (“a”), and PSMA expression reverses the phosphorylation of FAK-Tyr925, which is
    required for FAK/GRB2 interactions, thus inactivating ERK signal transduction
    (“b”). (C) Bypassing PSMA interference by directly activating FAK-Tyr925 with
    extracellular matrix (ECM) rescues activation of FAK-Tyr925 and the GRB2/ERK signaling
    pathway. (D) The absence of PSMA allows stable IGF-1R/RACK1/β1 integrin complex
    formation and activation of the FAK-GRB2-ERK canonical pathway, producing less
    aggressive tumors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R5
  - GRB2
  - PIK3R4
  - PDK1
  - PIK3R6
  - IGF1R
  - FOLH1
  - AKT3
  - MAPK3
  - MAPK1
  - PIK3CA
  - AKT2
  - PIK3CB
  - PIK3CD
  - PTK2
  - RACK1
  - AKT1
  - PIK3R3
  - PIK3CG
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PSMA
  symbol: PSMA
  source: hgnc_alias_symbol
  hgnc_symbol: FOLH1
  entrez: '2346'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: RACK1
  symbol: RACK1
  source: hgnc_symbol
  hgnc_symbol: RACK1
  entrez: '10399'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
chemicals: []
diseases: []
figid_alias: PMC5545931__F6
redirect_from: /figures/PMC5545931__F6
figtype: Figure
---
